LSAG
MRNA icon

Lake Street Advisors Group’s Moderna MRNA Stock Holding History

Lake Street Advisors Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,991
Closed -$474K – 655
2024
Q2 		$474K Buy
3,991
+253
+7% +$32K 0.02% 331
2024
Q1 		$398K Buy
3,738
+660
+21% +$66.5K 0.02% 385
2023
Q4 		$306K Buy
+3,078
New +$259K 0.02% 433
2021
Q3 		– Sell
-7,841
Closed -$3.07M – 356
2021
Q2 		$3.07M Buy
7,841
+143
+2% +$25.6K 0.23% 53
2021
Q1 		$1.01M Buy
7,698
+119
+2% +$17.2K 0.08% 99
2020
Q4 		$792K Sell
7,579
-467
-6% -$47.2K 0.07% 118
2020
Q3 		$569K Buy
+8,046
New +$561K 0.05% 129

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lake Street Advisors Group's MRNA Position: Q3 2024 in Review

Lake Street Advisors Group sold out of Moderna (MRNA) in Q3 2024, closing a stake of 3,991 shares — an estimated $474K sold.

Lake Street Advisors Group first reported a position in MRNA in Q3 2020 and held it in 7 quarters. The position peaked at $3.07M in Q2 2021. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Lake Street Advisors Group reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Lake Street Advisors Group sold 3,991 Moderna shares in Q3 2024, an estimated $474K.
  • Lake Street Advisors Group first reported a position in Moderna in Q3 2020 and held it in 7 quarters.
  • Lake Street Advisors Group's Moderna position peaked at $3.07M in Q2 2021.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Lake Street Advisors Group's 13F filing for Q3 2024, filed 23 Oct 2024.